Leonie Mayer

403 total citations
18 papers, 163 citations indexed

About

Leonie Mayer is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Animal Science and Zoology. According to data from OpenAlex, Leonie Mayer has authored 18 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Public Health, Environmental and Occupational Health and 4 papers in Animal Science and Zoology. Recurrent topics in Leonie Mayer's work include Streptococcal Infections and Treatments (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Leonie Mayer is often cited by papers focused on Streptococcal Infections and Treatments (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Leonie Mayer collaborates with scholars based in Germany, Netherlands and United States. Leonie Mayer's co-authors include Marylyn M. Addo, Anahita Fathi, Malte H. Wehmeyer, Thomas Theo Brehm, Armin Hoffmann, Martina Sterneck, Marc Lütgehetmann, Lutz Fischer, Friedrich Haag and Ansgar W. Lohse and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and The Lancet Infectious Diseases.

In The Last Decade

Leonie Mayer

13 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonie Mayer Germany 7 116 32 30 26 21 18 163
Sitthichai Kanokudom Thailand 11 313 2.7× 9 0.3× 36 1.2× 64 2.5× 62 3.0× 38 384
Waleed Aljabr Saudi Arabia 9 85 0.7× 10 0.3× 90 3.0× 16 0.6× 30 1.4× 20 195
Mami Nagashima Japan 8 138 1.2× 17 0.5× 58 1.9× 14 0.5× 18 0.9× 26 172
Luke Tzu-Chi Liu Taiwan 7 210 1.8× 22 0.7× 29 1.0× 87 3.3× 40 1.9× 12 243
Isabel Cervera Spain 7 122 1.1× 11 0.3× 68 2.3× 34 1.3× 28 1.3× 22 208
Cynthia Vázquez Paraguay 8 154 1.3× 27 0.8× 22 0.7× 28 1.1× 9 0.4× 14 203
Marjahan Akhtar Bangladesh 9 145 1.3× 7 0.2× 15 0.5× 3 0.1× 35 1.7× 16 247
Е. О. Самойлович Belarus 12 217 1.9× 15 0.5× 103 3.4× 29 1.1× 26 1.2× 27 289
Fatima Serhan Switzerland 11 171 1.5× 59 1.8× 80 2.7× 34 1.3× 74 3.5× 23 313
Le Nguyen Truc Nhu United Kingdom 9 94 0.8× 8 0.3× 108 3.6× 13 0.5× 38 1.8× 13 217

Countries citing papers authored by Leonie Mayer

Since Specialization
Citations

This map shows the geographic impact of Leonie Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonie Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonie Mayer more than expected).

Fields of papers citing papers by Leonie Mayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonie Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonie Mayer. The network helps show where Leonie Mayer may publish in the future.

Co-authorship network of co-authors of Leonie Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of Leonie Mayer. A scholar is included among the top collaborators of Leonie Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonie Mayer. Leonie Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mayer, Leonie, Anahita Fathi, Matthijs P. Raadsen, et al.. (2026). Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults. Nature Communications. 17(1). 480–480.
2.
Mellinghoff, Sibylle C., Martin Thelen, Michael von Bergwelt‐Baildon, et al.. (2025). Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD‐1 Inhibition as Potential Treatment Option. Mycoses. 68(3). e70044–e70044. 2 indexed citations
3.
Lehnert, Stefan, et al.. (2025). Autogenous Streptococcus suis serotype 1 bacterin: immunogenicities of sow and gilt vaccination protocols. Porcine Health Management. 11(1). 40–40.
4.
Jairoce, Chenjerai, Dídac Macià, Leonie Mayer, et al.. (2025). Role of malaria exposure and off-target responses on RTS,S/AS02A vaccine immunogenicity and protection in Mozambican children. npj Vaccines. 10(1). 116–116.
5.
Mellinghoff, Sibylle C., Sandra Robrecht, Rosanne Sprute, et al.. (2024). Hybrid immunity to SARS‐CoV ‐2 in patients with chronic lymphocytic leukemia. European Journal Of Haematology. 112(5). 788–793.
6.
Mayer, Leonie, Anahita Fathi, Maya Kono, et al.. (2024). MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans. npj Vaccines. 9(1). 20–20. 3 indexed citations
8.
Mayer, Leonie, et al.. (2024). Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates. Signal Transduction and Targeted Therapy. 9(1). 327–327. 5 indexed citations
11.
Raadsen, Matthijs P., Christine Dahlke, Anahita Fathi, et al.. (2024). Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial. The Lancet Infectious Diseases. 25(2). 231–242. 7 indexed citations
12.
Yoshida, Mari, et al.. (2022). Selection for nonspecific adhesion is a driver of FimH evolution increasing Escherichia coli biofilm capacity. PubMed. 3. uqac001–uqac001. 11 indexed citations
14.
Mayer, Leonie, et al.. (2022). A new S. suis serotype 3 infection model in pigs: lack of effect of buprenorphine treatment to reduce distress. BMC Veterinary Research. 18(1). 435–435. 6 indexed citations
15.
Haag, Friedrich, Thomas Theo Brehm, Anahita Fathi, et al.. (2021). SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients. Clinical Gastroenterology and Hepatology. 20(1). 162–172.e9. 100 indexed citations
16.
Mayer, Leonie, et al.. (2021). Survival patterns of Streptococcus suis serotypes 1 and 14 in porcine blood indicate cross-reactive bactericidal antibodies in naturally infected pigs. Veterinary Microbiology. 260. 109183–109183. 9 indexed citations
17.
Knappe, Daniel, et al.. (2020). Proline-rich antimicrobial peptide Api137 is bactericidal in porcine blood infected ex vivo with a porcine or human Klebsiella pneumoniae strain. Journal of Global Antimicrobial Resistance. 24. 127–135. 7 indexed citations
18.
Hennig‐Pauka, Isabel, et al.. (2019). From Stable to Lab—Investigating Key Factors for Sudden Deaths Caused by Streptococcus suis. Pathogens. 8(4). 249–249. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026